|
|
|
ANSWER TO QUESTION OF THE WEEK: (5/29/05)
If a person has already had hepatitis A (HAV) or has been exposed to HAV at any time in the past, he or she is protected from reinfection lifelong. Past exposure can be detected by obtaining a blood test for the hepatitis A antibody (HAV Ab). If a person tests positive for HAV Ab, there is no reason to get the vaccination because it will not provide any additional benefit. If the hepatitis A vaccine is administered to a person positive for HAV Ab no harm will be done, however. The hepatitis A vaccination will not protect a person from hepatitis B or C or from any form of hepatitis or liver disease other than hepatitis A.
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Palmer is an internationally renowned hepatologist who has been practicing medicine since 1985. Prior to 2012, she maintained perhaps the largest medical practice devoted to liver disease in the United States. Dr. Palmer is Clinical Professor of Medicine at New York University Medical Center. Dr. Palmer graduated from Columbia University with a B.A. and was trained in hepatology (as well as medical school) at the Mount Sinai School of Medicine in New York City.
Dr. Palmer is Board Certified in Gastroenterology and in Internal Medicine.
She has authored numerous scientific publications in the field of hepatology in such peer-reviewed journals as Hepatology, Gastroenterology, Seminars of Liver Disease, Transplantation and Archives of Internal Medicine.
She is frequently called upon by the media for her opinion on various topics related to liver disease. Dr. Palmer has appeared many times on television as a liver disease expert and has been quoted in such publications as TIME magazine, Cosmopolitan magazine, Prevention magazine, the Los Angeles Times, and Newsday. She also has appeared in numerous videos and CD-Roms aimed at educating doctors and the public about hepatitis C and other liver diseases, such as primary biliary cirrhosis. Dr. Palmer lectures to the medical and general public on liver disease-related topics on a regular basis.
Dr. Palmer has performed numerous clinical trials on various experimental medications for the treatment of hepatitis.
Dr. Palmer is currently available for lecturing, investor and hedge-fund consultations, consultations to industry, and media interviews and appearances-- including television. For such matters, she can be contacted through hepatitismedia@gmail.com.
Click on my picture to buy my book!
Return to liverdisease.com home page